CytoMed Chairman Buys More Shares
Ticker: GDTC · Form: 6-K · Filed: Oct 22, 2025 · CIK: 1873093
| Field | Detail |
|---|---|
| Company | Cytomed Therapeutics LTD (GDTC) |
| Form Type | 6-K |
| Filed Date | Oct 22, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | bullish |
Sentiment: bullish
Topics: insider-buy, shareholder-activity, disclosure
TL;DR
CytoMed Chairman Choo Chee Kong just bought 105,824 shares, signaling confidence.
AI Summary
On October 22, 2025, CytoMed Therapeutics Limited announced that its Executive Chairman and substantial shareholder, Mr. Choo Chee Kong, increased his stake in the company by purchasing 105,824 shares on the open market. This filing is a Form 6-K report.
Why It Matters
A substantial shareholder increasing their stake can signal confidence in the company's future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of a significant shareholder increasing their position, which is generally a positive or neutral event.
Key Numbers
- 105,824 — Shares Purchased (By Executive Chairman Mr. Choo Chee Kong)
Key Players & Entities
- CytoMed Therapeutics Limited (company) — Registrant
- Mr Choo Chee Kong (person) — Executive Chairman and substantial shareholder
- 105,824 shares (dollar_amount) — Number of shares purchased
- October 22, 2025 (date) — Date of press release and filing
FAQ
Who is Mr. Choo Chee Kong?
Mr. Choo Chee Kong is the Executive Chairman and a substantial shareholder of CytoMed Therapeutics Limited.
What action did Mr. Choo Chee Kong take?
Mr. Choo Chee Kong increased his shareholding in CytoMed Therapeutics Limited through open-market purchases of 105,824 shares.
When did this share purchase occur?
The press release announcing this action was issued on October 22, 2025.
What type of filing is this?
This is a Form 6-K report filed by CytoMed Therapeutics Limited.
What is the company's principal executive office address?
The company's principal executive office is located at 1 Commonwealth Lane #08-22, Singapore 149544.
Filing Stats: 222 words · 1 min read · ~1 pages · Grade level 12.5 · Accepted 2025-10-22 08:00:15
Filing Documents
- form6-k.htm (6-K) — 17KB
- ex99-1.htm (EX-99.1) — 12KB
- ex99-1_001.jpg (GRAPHIC) — 4KB
- 0001493152-25-018869.txt ( ) — 36KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CytoMed Therapeutics Limited By: /s/ CHOO Chee Kong Name: CHOO Chee Kong Date: October 22, 2025 Title: Director and Chairman